News

Kaftrio treatment associated with fewer sinus surgeries

People with cystic fibrosis (CF) who have chronic inflammation in the nose are less likely to need sinus surgery if they are taking the triple-combination CFTR modulator treatment Kaftrio (elexacaftor/tezacaftor/ivacaftor). That’s according to “Triple combination CFTR modulator therapy reduces the need for endoscopic sinus surgery…

Your CF Community


Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.